Gynius Plus AB

Gynius Plus AB, with the slogan "Striving to improve women's health around the world," was founded in 2014 in Sweden. The company's vision is to make women's healthcare more affordable, simple, and accessible, with their flagship product, the Gynocular, aimed at protecting millions of women from cervical cancer. After extensive research and development with clinical studies in Sweden, Bangladesh, and Uganda, the Gynocular was launched in the market. The company has since seen global adoption of its device in various settings and has been involved in new studies and applications. In December 2017, Gynius underwent a leadership change, with a new management team and owners with strong research backgrounds and international experience taking over. The company is committed to continuing its research and development efforts to bring more innovations to its customers. As of now, there is no available information on the headquarter, last investment, or the last investment's investors for Gynius Plus AB. Overall, Gynius Plus AB is a Swedish-based manufacturing company dedicated to revolutionizing women's health through its innovative and accessible healthcare solutions. With its Gynocular device and a team focused on research and development, the company is poised to make a significant impact in the global healthcare industry.